Chongqing Xinsaiya Biotechnology is Diagnostic Equipment in China that focus on developer business. Founded in 2016. They cover business area such as developer, producer, seller, (ivd, innovative ivd product, infectious disease, cardiovascular disease, renal disease, gastric disease, doctor, disease detection, treatment, medical cost.
2016
( 8 years old in 2024 )
Developer
-
No.388, Jingdongfang Avenue
Beibei District
Chongqing, 400714
China
Private
developerproducerseller(ivdinnovative ivd productinfectious diseasecardiovascular diseaserenal diseasegastric diseasedoctordisease detectiontreatmentmedical cost
* We use standard office opening hours in near Chongqing Xinsaiya Biotechnology's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Chongqing Xinsaiya Biotechnology is Diagnostic Equipment business from China that founded in 2016 (8 years old in 2024), Chongqing Xinsaiya Biotechnology business is focusing on Developer.
Chongqing Xinsaiya Biotechnology headquarter office and corporate office address is located in No.388, Jingdongfang Avenue Beibei District Chongqing, 400714 China.
Chongqing Xinsaiya Biotechnology was founded in China.
In 2024, Chongqing Xinsaiya Biotechnology is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Chongqing Xinsaiya Biotechnology, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.